Emily Wu
Partner @ Darwin Venture Management
Emily Wu is a seed investor at Darwin Venture Management focused on Medical and Analytics. Emily Wu
- Total investments:
- 1
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries Emily Wu invests in
Stages Emily Wu invests in
Countries Emily Wu invests in
Investment Focus
Industry
- Medical 1 (100%)
- Analytics 1 (100%)
- Biotechnology 1 (100%)
- Environmental Consulting 1 (100%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
BitBiome
|
BitBiome is a biotechnology company focused on analyzing microbial genomes and discovering enzymes and proteins that can be applied across industries such as pharmaceuticals, food production, and sustainable manufacturing. The company uses single-cell microbial sequencing technology to study microbes that are difficult to culture throughconventional laboratory methods, enabling the creation of a large microbial genome database called bit-GEM. Its platform supports enzyme discovery, genome analysis, and bioengineering efforts aimed at developing bio-based alternatives for industrial processes. bitBiome also works with academic institutions and commercial partners on research projects involving areas such as biodegradable materials, biomass conversion, and pharmaceutical ingredient synthesis. The company positions microbes as a resource for advancing the bioeconomy by providing tools and data that support biotechnology research and industrial applications. | Seed |
Co-Investors
About Darwin Venture Management
Darwin Venture Management is a venture capital firm headquartered in Taipei, Taiwan, with offices in Hsinchu and the United States. Since our founding in 2009, we have managed eight funds, investing primarily in Series A/B, late-stage, and secondary funds. In 2022, we also launched an evergreen angel fund to enable more nimble bets onpromising early-stage teams, and especially those coming from Taiwan’s superb academic and research institutions. This exposure across stages and borders, coupled with the strong technical background of our team, is the source of Darwin’s differentiation. We recently launched our 8th fund Darjune.
Darwin Venture Management Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Andrew Yang
Director
|
|||
|
Emily Wu
Partner
|
|||
Jason Lu
Investment Director
|
|||
Kay Lin
Managing Partner
|
|||
Kazuaki Konno
Venture Partner
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Emily Wu invest in?
Emily Wu invests primarily in Medical, Analytics and Biotechnology startups, most often at Seed stage. Most of the 1 investments tracked by Shizune back companies in Japan. The Investment Focus section breaks down every industry, stage and country in the portfolio.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
